Cell Meter™ Multiplexing Caspase 3/7, 8 and 9 Activity Assay Kit *Triple Fluorescence Colors*
Our Cell Meter™ assay kits are a set of tools for monitoring cell viability. There are a variety of parameters that can be used for monitoring cell viability. Caspases activation is widely accepted as a reliable indicator for cell apoptosis. This particular kit is designed to simultaneously monitor four key caspases (caspase-3/7, 8 and 9) activation involved in cell apoptosis using three distinct fluorescent colors. This kit uses DEVD-ProRed™, IETD-R110 and LEHD-AMC as fluorogenic indicators for caspase 3/7, 8 and 9 activity respectively. Upon caspase cleavages, DEVD-ProRed™, IETD-R110 and LEHD-AMC caspase substrates generate three distinct fluorophores: ProRed™ (red fluorescence), R110 (green fluorescence) and AMC (blue fluorescence), which can be readily monitored in a single assay due to their nice spectral separation.
Example protocol
AT A GLANCE
Protocol summary
- Prepare cells with test compounds
- Add equal volume of caspase working solution
- Incubate at room temperature for 30 min to 1 hour
- Monitor fluorescence intensity
Important notes
Thaw kit components at room temperature before use.
PREPARATION OF WORKING SOLUTION
1. Single caspase activity working solution
Make caspase 3/7, caspase 8 or caspase 9 working solution by adding 50 µL of substrate (Component A, B or C) into 10 mL of Assay Buffer (Component D), and mix them well.
2. Dual- or tri- caspase activity working solution:
Add 50 µL of each interested caspase substrate into 10 mL of Assay Buffer (Component D) together to make the working solution. Note: Please prepare the tested substrate solutions and the needed volume proportionally.
For guidelines on cell sample preparation, please visit
https://www.aatbio.com/resources/guides/cell-sample-preparation.html
SAMPLE EXPERIMENTAL PROTOCOL
- Treat cells by adding 10 µL/well of 10X test compounds (96-well plate) or 5 µL/well of 5X test compounds (384-plate) into PBS or the desired buffer. For blank wells (medium without the cells), add the same amount of compound buffer.
- Incubate the cell plate in a 37°C, 5% CO2, incubator for a desired period of time (3 - 5 hours for Jurkat cells treated with staurosporine) to induce apoptosis.
- Add 100 µL/well/96-well or 25 µL/well/384-well plate of desired caspase assay working solution.
- Incubate the plate at room temperature for at least 30 to 60 min, protected from light. Note: If desired, add 1 µL of 1 mM caspase inhibitor to selected samples 10 minutes before adding the assay loading solution at room temperature to confirm the inhibition of caspase activities.
- Monitor the fluorescence intensity as indicated in the table with either top or bottom read mode. Note: Sometimes, bottom read gives better signal to background ratio, centrifuge cell plate (especially for the nonadherent cells) at 800 rpm for 2 minutes (brake off) if using bottom read mode.
Table 1. Spectral wavelengths for Caspases 3/7, 8, and 9.
Capase | Fluorescence | Excitation | Emission |
Caspase 3/7 | Red | 535 nm | 620 nm |
Caspase 8 | Green | 490 nm | 525 nm |
Caspase 9 | Blue | 370 nm | 450 nm |
Citations
View all 27 citations: Citation Explorer
High-dose ascorbate exerts anti-tumor activities and improves inhibitory effect of carboplatin through the pro-oxidant function pathway in uterine serous carcinoma cell lines
Authors: Shen, Xiaochang and Wang, Jiandong and Deng, Boer and Chen, Shuning and John, Catherine and Zhao, Ziyi and Sinha, Nikita and Haag, Jennifer and Sun, Wenchuan and Kong, Weimin and others,
Journal: Gynecologic Oncology (2024): 93--102
Authors: Shen, Xiaochang and Wang, Jiandong and Deng, Boer and Chen, Shuning and John, Catherine and Zhao, Ziyi and Sinha, Nikita and Haag, Jennifer and Sun, Wenchuan and Kong, Weimin and others,
Journal: Gynecologic Oncology (2024): 93--102
Linoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer
Authors: Qiu, Jianqing and Zhao, Ziyi and Suo, Hongyan and Paraghamian, Sarah E and Hawkins, Gabrielle M and Sun, Wenchuan and Zhang, Xin and Hao, Tianran and Deng, Beor and Shen, Xiaochang and others,
Journal: Cancer Biology \& Therapy (2024): 2325130
Authors: Qiu, Jianqing and Zhao, Ziyi and Suo, Hongyan and Paraghamian, Sarah E and Hawkins, Gabrielle M and Sun, Wenchuan and Zhang, Xin and Hao, Tianran and Deng, Beor and Shen, Xiaochang and others,
Journal: Cancer Biology \& Therapy (2024): 2325130
Ipatasertib exhibits anti-tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer in vitro and in vivo
Authors: O'Donnell, Jillian and Zhao, Ziyi and Buckingham, Lindsey and Hao, Tianran and Suo, Hongyan and Zhang, Xin and Fan, Yali and John, Catherine and Deng, Boer and Shen, Xiaochang and others,
Journal: International Journal of Oncology (2023): 1--14
Authors: O'Donnell, Jillian and Zhao, Ziyi and Buckingham, Lindsey and Hao, Tianran and Suo, Hongyan and Zhang, Xin and Fan, Yali and John, Catherine and Deng, Boer and Shen, Xiaochang and others,
Journal: International Journal of Oncology (2023): 1--14
Microalga Chlorella sp. extract induced apoptotic cell death of cholangiocarcinoma via AKT/mTOR signaling pathway
Authors: Sawasdee, Nunghathai and Jantakee, Kanyaluck and Wathikthinnakon, Methi and Panwong, Suthida and Pekkoh, Jeeraporn and Duangjan, Kritsana and Yenchitsomanus, Pa-thai and Panya, Aussara
Journal: Biomedicine \& Pharmacotherapy (2023): 114306
Authors: Sawasdee, Nunghathai and Jantakee, Kanyaluck and Wathikthinnakon, Methi and Panwong, Suthida and Pekkoh, Jeeraporn and Duangjan, Kritsana and Yenchitsomanus, Pa-thai and Panya, Aussara
Journal: Biomedicine \& Pharmacotherapy (2023): 114306
Asparagus officinalis combined with paclitaxel exhibited synergistic anti-tumor activity in paclitaxel-sensitive and-resistant ovarian cancer cells
Authors: Zhang, Xin and Wang, Jiandong and Fan, Yali and Zhao, Ziyi and Paraghamian, Sarah E and Hawkins, Gabrielle M and Buckingham, Lindsey and O’Donnell, Jillian and Hao, Tianran and Suo, Hongyan and others,
Journal: Journal of Cancer Research and Clinical Oncology (2022): 1--13
Authors: Zhang, Xin and Wang, Jiandong and Fan, Yali and Zhao, Ziyi and Paraghamian, Sarah E and Hawkins, Gabrielle M and Buckingham, Lindsey and O’Donnell, Jillian and Hao, Tianran and Suo, Hongyan and others,
Journal: Journal of Cancer Research and Clinical Oncology (2022): 1--13
Page updated on November 21, 2024